These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3204001)

  • 41. Rationale and applications for macromolecular Gd-based contrast agents.
    Brasch RC
    Magn Reson Med; 1991 Dec; 22(2):282-7; discussion 300-3. PubMed ID: 1725917
    [No Abstract]   [Full Text] [Related]  

  • 42. Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration.
    Wang SC; White DL; Pope JM; Brasch RC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S44-5. PubMed ID: 2283253
    [No Abstract]   [Full Text] [Related]  

  • 43. Demonstration of vertebral body end plate veins by magnetic resonance imaging.
    Saywell WR; Crock HV; England JP; Steiner RE
    Br J Radiol; 1989 Mar; 62(735):290-2. PubMed ID: 2702391
    [No Abstract]   [Full Text] [Related]  

  • 44. Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MR imaging.
    Fletcher BD; Hanna SL
    Radiology; 1990 Oct; 177(1):287-8. PubMed ID: 2399334
    [No Abstract]   [Full Text] [Related]  

  • 45. Herpes trigeminal neuritis and rhombencephalitis on Gd-DTPA-enhanced MR imaging.
    Tien RD; Dillon WP
    AJNR Am J Neuroradiol; 1990; 11(2):413-4. PubMed ID: 2107732
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental otitis media evaluated by magnetic resonance imaging: an in vivo model.
    Chan KH; Swarts JD; Hashida Y; Doyle WJ; Kardatzke D; Wolf GL
    Ann Otol Rhinol Laryngol; 1992 Mar; 101(3):248-54. PubMed ID: 1543334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary artery sarcoma: evaluation using Gd-DTPA.
    Weinreb JC; Davis SD; Berkmen YM; Isom W; Naidich DP
    J Comput Assist Tomogr; 1990; 14(4):647-9. PubMed ID: 2370363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypercarbia-induced changes in cerebral blood volume in the cat: a 1H MRI and intravascular contrast agent study.
    Moseley ME; Chew WM; White DL; Kucharczyk J; Litt L; Derugin N; Dupon J; Brasch RC; Norman D
    Magn Reson Med; 1992 Jan; 23(1):21-30. PubMed ID: 1734180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic resonance contrast media for myocardial imaging.
    Higgins CB; Saeed M; Wendland MF
    Invest Radiol; 1990 Sep; 25 Suppl 1():S74. PubMed ID: 2283265
    [No Abstract]   [Full Text] [Related]  

  • 50. Contrast enhancement for the myocardium.
    Higgins CB; Saeed M; Wendland M
    Magn Reson Med; 1991 Dec; 22(2):347-53; discussion 364-5. PubMed ID: 1812369
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactions of paramagnetic contrast agents and the spin echo pulse sequence.
    Joseph PM
    Invest Radiol; 1989 Jun; 24(6):508-9. PubMed ID: 2562496
    [No Abstract]   [Full Text] [Related]  

  • 52. Paramagnetic dextrans as magnetic resonance contrast agents.
    Meyer D; Schaefer M; Bouillot A; Beauté S; Chambon C
    Invest Radiol; 1991 Nov; 26 Suppl 1():S50-2; discussion S60-4. PubMed ID: 1725521
    [No Abstract]   [Full Text] [Related]  

  • 53. Magnetic resonance angiography and use of contrast agents.
    Hartnell GG
    Lancet; 1992 Jan; 339(8785):124. PubMed ID: 1345848
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tophus of the base of the skull].
    Vogl T; Ballhaus J; Dresel S; Kang K
    Rofo; 1989 May; 150(5):613-4. PubMed ID: 2541494
    [No Abstract]   [Full Text] [Related]  

  • 55. Three dimensional magnetic resonance microangiography of rat neurovasculature.
    Mellin AF; Cofer GP; Smith BR; Suddarth SA; Hedlund LW; Johnson GA
    Magn Reson Med; 1994 Aug; 32(2):199-205. PubMed ID: 7968442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MRI study of a feline model of acute cerebral ischaemia. Contribution of paramagnetic contrast media to the diagnosis.
    Berry I; Brant-Zawadzki M; Manelfe C
    J Neuroradiol; 1988; 15(2):95-107. PubMed ID: 3216232
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a new MRI contrast agent targeted to inflammation.
    Laurent S; Vander Elst L; Fu Y; Muller RN
    Bioconjug Chem; 2004; 15(1):99-103. PubMed ID: 14733588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CNS imaging of neoplasms.
    Bragg DG; Osborn AG
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):841-5. PubMed ID: 1869474
    [No Abstract]   [Full Text] [Related]  

  • 59. Appropriate use of names for MR contrast media.
    Goldstein HA
    Radiology; 1990 Mar; 174(3 Pt 1):897. PubMed ID: 2305080
    [No Abstract]   [Full Text] [Related]  

  • 60. New methods for cost-performance assessment in diagnostic imaging.
    Wolf GL; Halpern E
    Invest Radiol; 1991 Nov; 26 Suppl 1():S12-4; discussion S15. PubMed ID: 1808105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.